Table 1.
Resistance Mechanism | Expected response to Apo2L/TRAIL | Expected response to lexatumumab (anti-DR5) | Expected response to maptumumab (anti-DR4) |
---|---|---|---|
DR5 mutation | No apoptosis | No apoptosis | Apoptosis |
Caspase-8 silencing | No apoptosis | No apoptosis | No apoptosis |
Increased XIAP | No apoptosis | No apoptosis | No apoptosis |
Increased DcR2 | No apoptosis | Apoptosis | Apoptosis |